Product Information
PIOGLITAZONE-METFORMIN 15-850 is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2750 per EA under NDC 33342017757. Its NADAC has been published 471 times since Aug 16, 2017.
FDA first approved this application on Nov 5, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
850; 15 mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342017757
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204802FDA Approved
11/5/2015
TE Code
AB
On Market Since
11/6/2015
Pharmacological Classes
Price Statistics
The NADAC for PIOGLITAZONE-METFORMIN 15-850 has been published 471 times since Aug 16, 2017, and over the history we have for it it has declined 76.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2750 per EA |
|---|---|
| All-time high | $1.1649 (Sep 13, 2017) |
| All-time low | $0.2180 (May 22, 2024) |
| 52-week high | $0.3035 |
| 52-week low | $0.2750 |
| Median price | $0.4785 |
| Average price | $0.5383 |
| Largest weekly change | -54.8% (Sep 20, 2023) |
| Weeks tracked | 471 |
| Tracking since | Aug 16, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PIOGLITAZONE-METFORMIN 15-850?
The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE-METFORMIN 15-850, manufactured by Macleods Pharmaceuticals Limited, is $0.2750 per EA (NDC 33342017757), effective Aug 19, 2026.
How has the price of PIOGLITAZONE-METFORMIN 15-850 changed over time?
Over the history we have for it, the NADAC for PIOGLITAZONE-METFORMIN 15-850 has declined 76.0%. It has been tracked across 471 weekly CMS publications since Aug 16, 2017.
What are the highest and lowest recorded NADAC prices for PIOGLITAZONE-METFORMIN 15-850?
Since Aug 16, 2017, the NADAC for PIOGLITAZONE-METFORMIN 15-850 has ranged from a low of $0.2180 (May 22, 2024) to a high of $1.1649 (Sep 13, 2017), with a median of $0.4785 per EA.
Are there cheaper alternatives to PIOGLITAZONE-METFORMIN 15-850?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PIOGLITAZONE-METFORMIN 15-850 in a comparable dosage form, but none are currently priced below it.
Who manufactures PIOGLITAZONE-METFORMIN 15-850?
PIOGLITAZONE-METFORMIN 15-850 (NDC 33342017757) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.